PER3 and breast cancer: Survival and differential co-expression data suggest that PER3 could be important modulating the relapse-free survival outcomes of LumA breast cancer patients by regulating cell cycle though mechanisms not fully elucidated that may involve loss of cell cycle control though decoupling of circadian function.